Quantcast

Latest Rebound effect Stories

More Efficient Lighting Increased More Light Consumption
2012-08-06 18:17:38

Two researchers have reprised in the journal Energy Policy their groundbreaking finding that improvements in lighting –  from candles to gas lamps to electric bulbs  – historically have led to increased light consumption rather than lower overall energy use by society. In an article in the journal Energy Policy, Sandia researcher Jeff Tsao and Harry Saunders of The Breakthrough Institute in Oakland, Calif., predicted in 2010 that the same phenomenon might apply to...

2009-07-06 08:35:24

People who begin taking proton pump inhibitors (PPIs) for heartburn generally continue to refill their prescriptions over time. New research out of Denmark is shedding light on why. In a study conducted in 120 healthy people who were randomized to receive eight weeks of treatment with a PPI followed by four weeks of a placebo or 12 weeks of a placebo alone, they find those taking the PPI experienced a rebound effect after stopping treatment with the active drug. Among that group, 44 percent...

2009-06-09 08:00:00

Analyses of Efficacy and Absence of Rebound Effect in a Clinical Study of Intermezzo(R) (Zolpidem Tartrate Sublingual Tablet 3.5 mg) to Treat Middle-of-the-Night (MOTN) Awakening on an As-Needed Basis RICHMOND, Calif., June 9 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today...

2008-09-09 15:00:09

-- Elderly patients taking LUNESTA 2 mg showed significant improvements in measures of daytime function compared to placebo over a 12-week treatment period -- Elderly patients administered LUNESTA 2 mg showed no evidence of rebound insomnia and withdrawal symptoms were comparable to the placebo group upon discontinuation Sepracor Inc. Jonae R. Barnes, 508-481-6700 Sr. Vice President, Investor Relations & Corporate Communications Sepracor Inc. (Nasdaq: SEPR) today announced the...

2008-09-03 09:00:08

Sepracor Inc. (Nasdaq: SEPR) today announced the presentation of LUNESTA(R) brand eszopiclone Phase IV study data at the 21st European College of Neuropsychopharmacology (ECNP) Congress in Barcelona. The poster presentations reflected results from a 12-week, double-blind, randomized safety and efficacy study of 388 elderly patients (65-85 years of age) who were administered either LUNESTA 2 mg or placebo nightly. Upon conclusion of the 12-week, double-blind treatment period, all patients...

2005-07-24 17:58:26

New Haven, Conn. -- The environmental impact of what we buy and use is increasingly drawing the attention of business, governments, and consumers. The connection between consumption and environmental impact is analyzed in new and important ways in a special issue of Yale's Journal of Industrial Ecology. Articles in the special issue analyze the environmental impact of consumption and U.S. house size, diet change, work time reduction, time use, product life spans and the quality of life....

2005-06-25 10:07:53

In trial, ramelteon helped users doze off and sleep longer HealthDay News -- The investigational drug ramelteon reduced the time it took for people with chronic insomnia to fall asleep and also increased their total sleep time, according to the results of a Phase III study sponsored by the drug's maker, Takeda Pharmaceuticals. The study also found no evidence of rebound insomnia, next-day impairments or withdrawal effects after people stopped using the drug. The U.S. Food and Drug...

2005-06-20 22:38:45

Denver, CO, June 20, 2005 "“ Ramelteon, a novel investigational compound under review with the FDA for the treatment of insomnia, reduced the time it took to fall asleep and increased total sleep time in adults with chronic insomnia, according to results from a Phase 3 study presented this week at the 19th Annual Meeting of the Associated Professional Sleep Societies (APSS). Results of the study also showed no evidence of rebound insomnia, next-day impairments or withdrawal effects due...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.